Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) EPS (Weighted Average and Diluted) (2017 - 2025)

cbdMD's EPS (Weighted Average and Diluted) history spans 9 years, with the latest figure at -$0.17 for Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 92.11% to -$0.17 in Q3 2025 year-over-year; TTM through Sep 2025 was -$0.17, a 92.11% increase, with the full-year FY2025 number at -$1.09, up 92.39% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.17 in Q3 2025 for cbdMD, up from -$2.14 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for YCBD hit a ceiling of $0.02 in Q2 2021 and a floor of -$11.77 in Q3 2022.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$1.88 across 5 years, with a median of -$0.35 in 2021.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): surged 109.4% in 2021 and later crashed 16717.39% in 2022.
  • Tracing YCBD's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.35 in 2021, then skyrocketed by 76.54% to -$0.08 in 2022, then crashed by 10061.44% to -$8.34 in 2023, then skyrocketed by 74.32% to -$2.14 in 2024, then soared by 92.11% to -$0.17 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for YCBD at -$0.17 in Q3 2025, -$2.14 in Q3 2024, and -$0.15 in Q2 2024.